Open for inclusion

A multicenter open randomised phase II study of the efficacy and safety of azacitidine alone or in combination with lenalidomide in high-risk myeloid disease (high-risk MDS and AML) with a karyotype including del(5q)

Cancer type: Leukemia

Phase: II

Principal Investigator: Noergaard Jan M.

Country: DK

Keywords: Denmark, Aarhus

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01556477?term=nmdsg10b&rank=1